Journal of Nuclear Cardiology

, Volume 25, Issue 2, pp 678–684 | Cite as

Multi-modality imaging: Bird’s eye view from the 2017 American Heart Association Scientific Sessions

  • Wael A. AlJaroudi
  • Steven G. Lloyd
  • Fadi G. Hage
Review Article


This review summarizes key imaging studies that were presented in the American Heart Association Scientific Sessions 2017 related to the fields of nuclear cardiology, cardiac computed tomography, cardiac magnetic resonance, and echocardiography. The aim of this bird’s eye view is to inform readers about multiple studies reported at the meeting from these different imaging modalities. While such a review is most useful for those that did not attend the conference, we find that a general overview may also be useful to those that did since it is often difficult to get exposure to many abstracts at large meetings. The review, therefore, aims to help readers stay updated on the newest imaging studies presented at the meeting and will hopefully stimulate new ideas for future research in imaging.


Echocardiography radionuclides magnetic resonance imaging computed tomography (CT) coronary blood flow 



Dr. Fadi Hage has received research grant support from Astellas Pharma. Drs. Aljaroudi and Lloyd declare that they have no conflict of interest.


  1. 1.
    Einstein AJ, Lloyd SG, Chaudhry FA, AlJaroudi WA, Hage FG. Multi-modality imaging: Bird’s eye view from the 2015 American Heart Association Scientific Sessions. J Nucl Cardiol 2016;23:235-43.CrossRefPubMedGoogle Scholar
  2. 2.
    AlJaroudi WA, Einstein AJ, Chaudhry FA, Lloyd SG, Hage FG. Multi-modality imaging: Bird’s-eye view from the 2014 American Heart Association Scientific Sessions. J Nucl Cardiol 2015;22:364-71.CrossRefPubMedGoogle Scholar
  3. 3.
    AlJaroudi WA, Lloyd SG, Chaudhry FA, Hage FG. Multi-modality imaging: Bird’s eye view from the 2016 American Heart Association Scientific Sessions. J Nucl Cardiol 2017;24:946-51.CrossRefPubMedGoogle Scholar
  4. 4.
    Saab R, Bajaj NS, Hage FG. Caffeine does not significantly reduce the sensitivity of vasodilator stress myocardial perfusion imaging. J Nucl Cardiol 2016;23:442-6.CrossRefPubMedGoogle Scholar
  5. 5.
    Reyes E. Caffeine reduces the sensitivity of vasodilator MPI for the detection of myocardial ischaemia: Pro. J Nucl Cardiol 2016;23:447-53.CrossRefPubMedGoogle Scholar
  6. 6.
    Saab R, Bajaj NS, Hage FG. Caffeine intake and myocardial perfusion imaging. J Nucl Cardiol 2016;23:605.CrossRefPubMedGoogle Scholar
  7. 7.
    Reyes E. Caffeine does not significantly reduce the sensitivity of vasodilator stress MPI: Rebuttal. J Nucl Cardiol 2016;23:604.CrossRefPubMedGoogle Scholar
  8. 8.
    Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, et al Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol 2017. Scholar
  9. 9.
    Iskandrian AE, Dilsizian V, Garcia EV, Beanlands RS, Cerqueira M, Soman P, et al Myocardial perfusion imaging: Lessons learned and work to be done-update. J Nucl Cardiol 2017. Scholar
  10. 10.
    Payne GA, Hage FG, Acharya D. Transplant allograft vasculopathy: Role of multimodality imaging in surveillance and diagnosis. J Nucl Cardiol 2016;23:713-27.CrossRefPubMedGoogle Scholar
  11. 11.
    Hammad B, Evans NR, Rudd JHF, Tawakol A. Molecular imaging of atherosclerosis with integrated PET imaging. J Nucl Cardiol 2017;24:938-43.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    AlJaroudi W. Mechanical dyssynchrony with phase analysis of gated SPECT: Nap time is over. J Nucl Cardiol 2017. Scholar
  13. 13.
    Hartaigh BO, Valenti V, Cho I, Schulman-Marcus J, Gransar H, Knapper J, et al 15-Year prognostic utility of coronary artery calcium scoring for all-cause mortality in the elderly. Atherosclerosis 2016;246:361-6.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Khawaja T, Greer C, Thadani SR, Kato TS, Bhatia K, Shimbo D, et al Increased regional epicardial fat volume associated with reversible myocardial ischemia in patients with suspected coronary artery disease. J Nucl Cardiol 2015;22:325-33.CrossRefPubMedGoogle Scholar
  15. 15.
    Scatteia A, Baritussio A, Bucciarelli-Ducci C. Strain imaging using cardiac magnetic resonance. Heart Fail Rev 2017;22:465-76.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Sadat K, Ather S, Aljaroudi W, Heo J, Iskandrian AE, Hage FG. The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion. J Nucl Cardiol 2014;21:351-67.CrossRefPubMedGoogle Scholar
  17. 17.
    Yoshida Y, Yamanaka S. Induced pluripotent stem cells 10 years later: For cardiac applications. Circ Res 2017;120:1958-68.CrossRefPubMedGoogle Scholar
  18. 18.
    Jimenez Juan L, Crean AM, Wintersperger BJ. Late gadolinium enhancement imaging in assessment of myocardial viability: Techniques and clinical applications. Radiol Clin North Am 2015;53:397-411.CrossRefPubMedGoogle Scholar
  19. 19.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017;70:252-89.CrossRefPubMedGoogle Scholar
  20. 20.
    Rizk DV, Riad S, Hage FG. Screening for coronary artery disease in kidney transplant candidates. J Nucl Cardiol 2015;22:297-300.CrossRefPubMedGoogle Scholar
  21. 21.
    Farag AA, AlJaroudi W, Neill J, Doppalapudi H, Kumar V, Rizk D, et al Prognostic value of silent myocardial infarction in patients with chronic kidney disease being evaluated for kidney transplantation. Int J Cardiol 2017;249:377-82.CrossRefPubMedGoogle Scholar
  22. 22.
    Hage FG, Smalheiser S, Zoghbi GJ, Perry GJ, Deierhoi M, Warnock D, et al Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol 2007;100:1020-5.CrossRefPubMedGoogle Scholar
  23. 23.
    Cao WJ, Rosenblat JD, Roth NC, Kuliszewski MA, Matkar PN, Rudenko D, et al Therapeutic angiogenesis by ultrasound-mediated MicroRNA-126-3p delivery. Arterioscler Thromb Vasc Biol 2015;35:2401-11.CrossRefPubMedGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2018

Authors and Affiliations

  • Wael A. AlJaroudi
    • 1
  • Steven G. Lloyd
    • 2
    • 3
  • Fadi G. Hage
    • 2
    • 3
  1. 1.Division of Cardiovascular MedicineClemenceau Medical CenterBeirutLebanon
  2. 2.Division of Cardiovascular DiseaseUniversity of Alabama at BirminghamBirminghamUSA
  3. 3.Section of CardiologyBirmingham Veterans Affairs Medical CenterBirminghamUSA

Personalised recommendations